XML 35 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF DISAGGREGATED REVENUE

For the years ended December 31, 2021 and 2020, the Company had the following disaggregated revenue:

 

   Year Ended December 31, 
   2021   %   2020   % 
                 
Telehealth revenue  $68,197,128    73%  $30,561,163    82%
WorkSimpli revenue   24,678,678    27%   6,732,747    18%
Total net revenue  $92,875,806    100%  $37,293,910    100%
SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

The Company records deferred revenues when cash payments are received or due in advance of its performance. The Company’s deferred revenues relate to payments received for the in-process monthly or yearly contracts with customers and a portion attributable to the yet to be recognized initial 14-day trial period collections.

 

   2021   2020 
   Year Ended December 31, 
   2021   2020 
Beginning of period  $916,880   $109,552 
Additions   23,430,037    6,885,766 
Revenue recognized   (22,847,037)   (6,078,438)
End of period  $1,499,880   $916,880 
SUMMARY OF INVENTORY

As of December 31, 2021 and 2020, the Company’s inventory consisted of the following:

 

   2021   2020 
   December 31, 
   2021   2020 
         
Finished Goods - Products  $1,592,654   $1,172,624 
Raw materials and packaging components   81,427    149,115 
Inventory reserve   (57,481)   (57,481)
Total Inventory - net  $1,616,600   $1,264,258 
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares:

 

   Year Ended December 31, 
   2021   2020 
         
Series B Convertible Preferred Stock   1,264,868    1,124,868 
Restricted Stock Units (RSUs)   975,375    - 
Stock options   4,257,233    4,232,400 
Warrants   3,888,438    3,550,471 
Potentially dilutive securities   10,385,914    8,907,739